Benzodiazepines and Related Sedatives.
Peng L, Morford KL, Levander XA.
Med Clin North Am. 2022 Jan;106(1):113-129. doi: 10.1016/j.mcna.2021.08.012.
Benzodiazepine harm: how can it be reduced?
Lader M.
Br J Clin Pharmacol. 2014 Feb;77(2):295-301. doi: 10.1111/j.1365-2125.2012.04418.x.
Time trends in hospitalizations with anxiolytic, sedative, or hypnotic drug use disorder: a 17-year U.S. national study.
Singh J.
J Addict Dis. 2022 Jan-Mar;40(1):4-11. doi: 10.1080/10550887.2021.1911563. Epub 2021 Apr 22.
Prevalence of concomitant use of alcohol and sedative-hypnotic drugs in middle and older aged persons: a systematic review.
Ilomäki J, Paljärvi T, Korhonen MJ, Enlund H, Alderman CP, Kauhanen J, Bell JS.
Ann Pharmacother. 2013 Feb;47(2):257-68. doi: 10.1345/aph.1R449. Epub 2013 Jan 29.
Sedative-hypnotic dependence.
Fink RD, Knott DH, Beard JD.
Am Fam Physician. 1974 Sep;10(3):116-22.
Nationwide trends in diagnosed sedative, hypnotic or anxiolytic use disorders in adolescents and young adults enrolled in Medicaid: 2001-2019.
Bushnell G, Lloyd K, Olfson M, Gerhard T, Keyes K, Cerdá M, Hasin D.
Addiction. 2025 May;120(5):951-961. doi: 10.1111/add.16749. Epub 2025 Jan 22.
Ethanol and sedatives.
Greenberg DA.
Neurol Clin. 1993 Aug;11(3):523-34.
DARK Classics in Chemical Neuroscience: Methaqualone.
Inger JA, Mihan ER, Kolli JU, Lindsley CW, Bender AM.
ACS Chem Neurosci. 2023 Feb 1;14(3):340-350. doi: 10.1021/acschemneuro.2c00697. Epub 2023 Jan 18.
History and current status of sedative-hypnotic drug use and abuse.
Allgulander C.
Acta Psychiatr Scand. 1986 May;73(5):465-78. doi: 10.1111/j.1600-0447.1986.tb02713.x.
Substance abuse and insomnia.
Rosenblum M.
Minn Med. 2017 May;100(3):38-39.
